Spoken Alpha · Executive

Jonathan Violin

Chief Executive OfficerVRDNViridian Therapeutics, Inc.\DE

In our data from May 2, 2022

Tracked across 4 earnings calls in our data since 2022.

Role timeline

VRDNViridian Therapeutics, Inc.\DE
Chief Executive Officer
May 2, 2022 – May 2, 2022 · source: edgar_form4
VRDNViridian Therapeutics, Inc.\DE
Chief Executive Officer
Feb 1, 2022 – Feb 2, 2023 · source: edgar_form4
VRDNViridian Therapeutics, Inc.\DE
See Remarks
Dec 8, 2021 – Dec 8, 2021 · source: edgar_form4
VRDNViridian Therapeutics, Inc.\DE
CEO and President
Jan 18, 2021 – Jan 18, 2021 · source: edgar_form4
VRDNViridian Therapeutics, Inc.\DE
President and COO
Oct 27, 2020 – Oct 27, 2020 · source: edgar_form4

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

4 calls

VRDNQ3 FY2022Nov 14, 2022

Viridian Therapeutics, Inc.\DE

VRDNQ2 FY2022Aug 15, 2022

Viridian Therapeutics, Inc.\DE

VRDNQ1 FY2022May 12, 2022

Viridian Therapeutics, Inc.\DE

VRDNQ4 FY2021Mar 10, 2022

Viridian Therapeutics, Inc.\DE